160 related articles for article (PubMed ID: 33475987)
1. The course of cervical spinal cord atrophy rate and its relationship with NEDA in relapsing remitting multiple sclerosis.
Cilingir V; Akdeniz H
Acta Neurol Belg; 2022 Apr; 122(2):345-355. PubMed ID: 33475987
[TBL] [Abstract][Full Text] [Related]
2. Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability.
Mina Y; Azodi S; Dubuche T; Andrada F; Osuorah I; Ohayon J; Cortese I; Wu T; Johnson KR; Reich DS; Nair G; Jacobson S
Neuroimage Clin; 2021; 30():102680. PubMed ID: 34215150
[TBL] [Abstract][Full Text] [Related]
3. Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis.
Valsasina P; Gobbi C; Zecca C; Rovira A; Sastre-Garriga J; Kearney H; Yiannakas M; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Filippi M; Rocca MA;
Mult Scler; 2022 May; 28(6):885-899. PubMed ID: 34605323
[TBL] [Abstract][Full Text] [Related]
4. Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis.
Tsagkas C; Huck-Horvath A; Cagol A; Haas T; Barakovic M; Amann M; Ruberte E; Melie-Garcia L; Weigel M; Pezold S; Schlaeger R; Kuhle J; Sprenger T; Kappos L; Bieri O; Cattin P; Granziera C; Parmar K
Mult Scler; 2023 May; 29(6):702-718. PubMed ID: 36550626
[TBL] [Abstract][Full Text] [Related]
5. Upper cervical cord atrophy is independent of cervical cord lesion volume in early multiple sclerosis: A two-year longitudinal study.
Weeda MM; Zywicki S; Brouwer I; Moraal B; Killestein J; Gallo P; Barkhof F; Pouwels PJW; Vrenken H
Mult Scler Relat Disord; 2022 Apr; 60():103713. PubMed ID: 35272146
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis lesions and atrophy in the spinal cord: Distribution across vertebral levels and correlation with disability.
Bussas M; El Husseini M; Harabacz L; Pineker V; Grahl S; Pongratz V; Berthele A; Riederer I; Zimmer C; Hemmer B; Kirschke JS; Mühlau M
Neuroimage Clin; 2022; 34():103006. PubMed ID: 35468568
[TBL] [Abstract][Full Text] [Related]
7. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
[TBL] [Abstract][Full Text] [Related]
8. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
[TBL] [Abstract][Full Text] [Related]
9. Correlation between EDSS scores and cervical spinal cord atrophy at 3T MRI in multiple sclerosis: A systematic review and meta-analysis.
Song X; Li D; Qiu Z; Su S; Wu Y; Wang J; Liu Z; Dong H
Mult Scler Relat Disord; 2020 Jan; 37():101426. PubMed ID: 32172997
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal assessment of cervical spinal cord compartments in multiple sclerosis.
Tsagkas C; Huck-Horvath A; Cagol A; Haas T; Amann M; Barakovic M; Ruberte E; Melie-Garcia L; Weigel M; Pezold S; Schlaeger R; Kuhle J; Sprenger T; Kappos L; Bieri O; Cattin P; Granziera C; Parmar K
Mult Scler Relat Disord; 2023 Mar; 71():104545. PubMed ID: 36758461
[TBL] [Abstract][Full Text] [Related]
11. Atrophy and structural variability of the upper cervical cord in early multiple sclerosis.
Biberacher V; Boucard CC; Schmidt P; Engl C; Buck D; Berthele A; Hoshi MM; Zimmer C; Hemmer B; Mühlau M
Mult Scler; 2015 Jun; 21(7):875-84. PubMed ID: 25139943
[TBL] [Abstract][Full Text] [Related]
12. Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis.
Lundell H; Svolgaard O; Dogonowski AM; Romme Christensen J; Selleberg F; Soelberg Sørensen P; Blinkenberg M; Siebner HR; Garde E
Acta Neurol Scand; 2017 Oct; 136(4):330-337. PubMed ID: 28070886
[TBL] [Abstract][Full Text] [Related]
13. Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis.
Bischof A; Papinutto N; Keshavan A; Rajesh A; Kirkish G; Zhang X; Mallott JM; Asteggiano C; Sacco S; Gundel TJ; Zhao C; Stern WA; Caverzasi E; Zhou Y; Gomez R; Ragan NR; Santaniello A; Zhu AH; Juwono J; Bevan CJ; Bove RM; Crabtree E; Gelfand JM; Goodin DS; Graves JS; Green AJ; Oksenberg JR; Waubant E; Wilson MR; Zamvil SS; ; Cree BAC; Hauser SL; Henry RG
Ann Neurol; 2022 Feb; 91(2):268-281. PubMed ID: 34878197
[TBL] [Abstract][Full Text] [Related]
14. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J
Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing-Remitting Multiple Sclerosis.
Singhal T; Tauhid S; Hurwitz S; Neema M; Bakshi R
J Neuroimaging; 2017 Jan; 27(1):33-36. PubMed ID: 27466943
[TBL] [Abstract][Full Text] [Related]
16. Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis.
Bonacchi R; Pagani E; Meani A; Cacciaguerra L; Preziosa P; De Meo E; Filippi M; Rocca MA
Radiology; 2020 Sep; 296(3):605-615. PubMed ID: 32573387
[TBL] [Abstract][Full Text] [Related]
17. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
Azodi S; Nair G; Enose-Akahata Y; Charlip E; Vellucci A; Cortese I; Dwyer J; Billioux BJ; Thomas C; Ohayon J; Reich DS; Jacobson S
Ann Neurol; 2017 Nov; 82(5):719-728. PubMed ID: 29024167
[TBL] [Abstract][Full Text] [Related]
18. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
Barro C; Benkert P; Disanto G; Tsagkas C; Amann M; Naegelin Y; Leppert D; Gobbi C; Granziera C; Yaldizli Ö; Michalak Z; Wuerfel J; Kappos L; Parmar K; Kuhle J
Brain; 2018 Aug; 141(8):2382-2391. PubMed ID: 29860296
[TBL] [Abstract][Full Text] [Related]
19. 7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis.
Ouellette R; Treaba CA; Granberg T; Herranz E; Barletta V; Mehndiratta A; De Leener B; Tauhid S; Yousuf F; Dupont SM; Klawiter EC; Sloane JA; Bakshi R; Cohen-Adad J; Mainero C
Brain; 2020 Oct; 143(10):2973-2987. PubMed ID: 32935834
[TBL] [Abstract][Full Text] [Related]
20. Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability.
Valsasina P; Aboulwafa M; Preziosa P; Messina R; Falini A; Comi G; Filippi M; Rocca MA
Radiology; 2018 Jul; 288(1):234-244. PubMed ID: 29664341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
